We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+13.75%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$1.65B
AUM Growth
+$174M
Cap. Flow
-$8.92M
Cap. Flow %
-0.54%
Top 10 Hldgs %
25.13%
Holding
665
New
94
Increased
200
Reduced
269
Closed
61

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$18.5M
2
AMAT icon
Applied Materials
AMAT
+$12.6M
3
UNP icon
Union Pacific
UNP
+$5.43M
4
MO icon
Altria Group
MO
+$4.98M
5
RTX icon
RTX Corp
RTX
+$4.12M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$15.4M
2
BIIB icon
Biogen
BIIB
+$14.7M
3
ORCL icon
Oracle
ORCL
+$5.14M
4
TJX icon
TJX Companies
TJX
+$3.58M
5
MMM icon
3M
MMM
+$3.57M

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 15.54%
3 Financials 14.47%
4 Consumer Staples 11.33%
5 Consumer Discretionary 11.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
51
McDonald's
MCD
$196B
$5.97M 0.36%
31,441
-925
-3% -$168K
PM icon
52
Philip Morris
PM
$293B
$5.95M 0.36%
67,331
-2,850
-4% -$230K
ADBE icon
53
Adobe
ADBE
$103B
$5.93M 0.36%
22,270
-3,275
-13% -$826K
CRM icon
54
Salesforce
CRM
$153B
$5.85M 0.36%
36,936
-2,000
-5% -$310K
LOW icon
55
Lowe's Companies
LOW
$122B
$5.46M 0.33%
49,926
+4,310
+9% +$430K
AVGO icon
56
Broadcom
AVGO
$2T
$5.19M 0.32%
172,630
-36,750
-18% -$996K
GILD icon
57
Gilead Sciences
GILD
$162B
$4.92M 0.3%
75,740
-1,400
-2% -$93.1K
RTX icon
58
RTX Corp
RTX
$301B
$4.91M 0.3%
60,574
+54,216
+853% +$4.12M
AXP icon
59
American Express
AXP
$231B
$4.77M 0.29%
43,630
+4,785
+12% +$503K
TMO icon
60
Thermo Fisher Scientific
TMO
$214B
$4.63M 0.28%
16,925
+4,700
+38% +$1.17M
GE icon
61
GE Aerospace
GE
$389B
$4.58M 0.28%
91,930
-10,527
-10% -$496K
LMT icon
62
Lockheed Martin
LMT
$135B
$4.57M 0.28%
15,228
-750
-5% -$220K
CVX icon
63
Chevron
CVX
$371B
$4.52M 0.27%
36,709
+370
+1% +$43.8K
PYPL icon
64
PayPal
PYPL
$51.1B
$4.44M 0.27%
42,800
-825
-2% -$78.1K
COST icon
65
Costco
COST
$421B
$4.41M 0.27%
18,202
-6,095
-25% -$1.33M
ADP icon
66
Automatic Data Processing
ADP
$109B
$4.21M 0.26%
26,350
-2,425
-8% -$352K
DD icon
67
DuPont de Nemours
DD
$19.5B
$4.13M 0.25%
30,610
-1,145
-4% -$159K
CVS icon
68
CVS Health
CVS
$123B
$4.08M 0.25%
75,582
+29,920
+66% +$1.85M
DHR icon
69
Danaher
DHR
$141B
$4.07M 0.25%
34,810
-3,170
-8% -$325K
GS icon
70
Goldman Sachs
GS
$301B
$3.92M 0.24%
20,400
+2,199
+12% +$424K
INTU icon
71
Intuit
INTU
$88.1B
$3.67M 0.22%
+14,025
New +$3.24M
EW icon
72
Edwards Lifesciences
EW
$51.5B
$3.6M 0.22%
56,364
+23,100
+69% +$1.32M
ROST icon
73
Ross Stores
ROST
$81.6B
$3.51M 0.21%
37,685
+300
+0.8% +$27.5K
LIN icon
74
Linde
LIN
$226B
$3.42M 0.21%
19,465
-350
-2% -$58.1K
BIIB icon
75
Biogen
BIIB
$30.5B
$3.35M 0.2%
14,191
-46,749
-77% -$14.7M

Similar funds

Oakbrook Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Oakbrook Investments held 665 positions worth $1.65B, up 12% from $1.47B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Oakbrook Investments's Q1 2019 filing shows 94 new, 200 increased, 269 reduced and 61 closed positions. Its largest new stake was Intuit: 14,025 shares worth $3.67M. The largest sale was Qualcomm, an estimated $15.4M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Oakbrook Investments's largest Q1 2019 buy was Intuit: 14,025 shares worth $3.67M.
  • Oakbrook Investments added most to AbbVie in Q1 2019, an estimated $18.5M increase.
  • Oakbrook Investments's biggest Q1 2019 reduction was Biogen, cutting an estimated $14.7M.
  • Oakbrook Investments fully exited Qualcomm in Q1 2019, selling an estimated $15.4M.
  • Oakbrook Investments's ten largest holdings make up 25% of its $1.65B portfolio in Q1 2019.
  • Oakbrook Investments opened 94 new positions and closed 61 in Q1 2019.
  • Oakbrook Investments's portfolio value rose 12% quarter-over-quarter to $1.65B.

Based on Oakbrook Investments's 13F filing for Q1 2019, filed 18 Apr 2019.